Baylor Scott and White   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Dallas TX United States (1903)

Organization Overview

First Clinical Trial
2004
NCT00103766
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Baylor Scott and White | Baylor Scott and White Health | Baylor Scott and White Institute for Rehabilitation | O'Brien, Jeana D., MD, FACP, FCCP